Bette Monnot-Chase

Bette Monnot-Chase has extensive experience in the pharmaceutical industry, with a focus on analytical sciences and CMC (Chemistry, Manufacturing, and Controls) aspects of drug development. Bette currently holds the position of Sr. Director, Analytical Sciences at Marinus Pharma, where they have been working since 2020. Prior to this role, they served as the Director of Analytical Sciences at the same company from 2020 to 2022.

Before joining Marinus Pharma, Bette worked at Asklepion Pharmaceuticals LLC as the Director of CMC and Quality from 2016 to 2020. In this role, they were responsible for overseeing the chemistry, manufacturing, and quality aspects of the company's products.

Bette also has experience at Shire, where they held multiple roles from 2014 to 2016. Bette worked as a Technical Consultant for Transactions and later as an Associate Director of Product Development. In these positions, they managed the outsourcing of drug production, developed regulatory strategies, and prepared CMC sections for regulatory documents.

Prior to their time at Shire, Bette worked at ViroPharma Incorporated as the Assistant Director of CMC from 2006 to 2014. In this role, they managed the outsourcing of drug production, participated in the development of regulatory strategies, and wrote CMC sections for regulatory documents.

Earlier in their career, Bette held positions at Cephalon, where they served as the Manager of Stability from 2004 to 2006, and at Catalent Pharma Solutions, where they worked as a Senior Scientist II from 1998 to 2003. At Cephalon, they managed the corporate Stability group and oversaw stability programs for a range of drug products. At Catalent Pharma Solutions, they managed scientific projects and a team of analysts.

Bette's career in the pharmaceutical industry began at Searle in 1989, where they held roles of increasing responsibility. Bette started as a Senior Research Investigator/Research Investigator, supporting formulation development activities and managing a team of scientists. Later, they became a Senior Scientist I, overseeing formulation development and managing a larger team.

Overall, Bette Monnot-Chase's work experience demonstrates their expertise in analytical sciences, CMC, and formulation development in the pharmaceutical industry.

Bette Monnot-Chase earned a Bachelor of Science degree in Chemistry from Bowling Green State University in 1983. From 1983-1990, they pursued their PhD in Pharmaceutical Sciences at The University of Kansas.